Immunotherapy employment in patient with infection produced by Staphylococcus aureus

Authors

  • Sandra Adela Naranjo Rodríguez Universidad de Ciencias Médicas de Matanzas
  • Rodobaldo García Menéndez Hospital Universitario Clínico-Quirúrgico Comandante Faustino Pérez. Matanzas
  • Lisandra Naranjo Rodríguez Centro Provincial de Higiene, Epidemiología y Microbiología. Matanzas
  • Marisel Negret Hernández Universidad de Ciencias Médicas de Matanzas

Keywords:

skin diseases infectious, Staphylococcus aureus, immunotherapy, autovaccines, clinical trial phase II, treatment outcome

Abstract

The skin infection by Staphylococcus aureus is currently a health problem in our population, because of its high frequency, resistance to the antibiotic therapy and its complications. We carried out a randomized, open, controlled, phase II clinical trial, with the objective of demonstrating the therapeutic effect and safety of the autovaccine as a treatment of the Staphylococcus infections. 457 patients with a diagnosis of Staphylococcus aureus in skin lesions were included, and they were divided in two groups. Group A (237 patients), received the autovaccine obtained form the micro organism isolated in each subject, and group B (220 patients), received antibiotic treatment according to the antibiogram results. With the application of the autovaccine, we obtained 82 % of healing, and only 10 % of the patients had the reappearance of furuncles in an interval of 6 months after finishing the treatment. However, with the application of the antibiotic therapy there was 12 % of healing and 75 % of reappearance of the furuncles in the mentioned time interval. The autovaccine was more effective in the treatment of the bacterial infection by Staphylococcus aureus that the antimicrobial agents besides being a good tolerated immunotherapy for most of the patients.

Downloads

Download data is not yet available.

How to Cite

1.
Naranjo Rodríguez SA, García Menéndez R, Naranjo Rodríguez L, Negret Hernández M. Immunotherapy employment in patient with infection produced by Staphylococcus aureus. Rev Méd Electrón [Internet]. 2014 Mar. 27 [cited 2025 Apr. 13];33(2):188-94. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/824

Issue

Section

Research article